Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase Ib, Dose Escalation Study of Lithium When Added to Standard Chemotherapy of Oxaliplatin and Capecitabine in Patients With Advanced Oesophago-Gastric or Colorectal Cancer

NCT03153280 is registered in ClinicalTrials.gov with Cancer Trials Ireland as lead sponsor.

NCT NCT03153280
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03153280 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase Ib, Dose Escalation Study of Lithium When Added to Standard Chemotherapy of Oxaliplatin and Capecitabine in Patients With Advanced Oesophago-Gastric or Colorectal Cancer
Lead sponsor
Cancer Trials Ireland
Phase
Phase 1
Overall status
Terminated
Start date
January 13, 2022
Completion date
September 7, 2023
Enrollment
2 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal neoplasms, esophageal neoplasms, stomach neoplasm